Thank you for taking the time to learn more about our team at Physio PS.
Our mission at Physio PS is to improve the way people understand, respond to imbalances in the Autonomic Nervous System and how it relates to their overall health and well-being.
With many years of research and development of this incredibly unique means of monitoring the ANS. Doctors throughout the world use our technology to improve the lives of their patients and better the outcome of treatment.
We are driven to make A.N.S. monitoring a standard in care. Giving people access to this proprietary technology is a goal that was established by one of the company’s founders, Steve O’Leary.
Steve was introduced to this technology and he received insight into his health that had previously been overlooked. Thinking he was a healthy and fit product of the “Baby Boomer” generation, he was a regular at his local gym and maintained a healthy diet. After receiving an annual physical and stress test he was given the green light to continue his routines. Little did he know, there was a secret that the annual exam had not uncovered….
After meeting the doctor who invented this technology, he was extremely interested about the potential to save lives. As he began to understand the technology, he wanted a monitoring session preformed for himself.
Little did he know, this non-invasive, 15-minute monitoring session would save his life!
Steve was given a A.N.S. monitoring session and the results were alarming! Had he only known…. His heart was a silently ticking time bomb! Steve was diagnosed with Cardiac Autonomic Neuropathy or CANS… A deadly, secret killer!
Steve is in great health today and is happy that he was given the opportunity to mitigate CANS with proper medical attention.
After seeing the power of this simple 15-minute monitoring session, Physio PS was born!
Now Steve has a team of people that work every step of the way to share this amazing technology. We have amazing doctors, support staff and leaders that are working to make this technology available to the masses and improve the way doctors care for their patients.
‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.